Cite
MLA Citation
Claire Roddie et al.. “Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.” Journal of clinical oncology, vol. 39, no. 30, 2021, pp. 3352–3363. http://access.bl.uk/ark:/81055/vdc_100150609950.0x00002a